BioCorRx (BICX) FCF Margin (2011 - 2026)
BioCorRx (BICX) reported FCF Margin of -201.81% for Q1 2026, up 309.40 percentage points from -511.21% a year earlier.
Powered by 
Analysis
BioCorRx (BICX) FCF Margin (2011 - 2026) Analysis & Trends
Over the twelve months ended Mar 31, 2026, BioCorRx's FCF Margin came in at -232.83%, up 808.03 percentage points year-over-year; for FY2025, it was -288.28%, up 14013.79 percentage points from FY2024.
- FCF Margin has a five-year change of +1474.14 percentage points (FY2020 to FY2025).
- By year, FCF Margin came in at -14302.07% in FY2024 (-12223.47 pp), -2078.60% in FY2023 (-1123.79 pp), -954.81% in FY2022 (+6377.96 pp) and -7332.77% in FY2021 (-5570.35 pp).
- Five-year quarterly FCF Margin spans a low of -9383.09% in Q1 2024 and a high of -70.97% in Q2 2025.
- Year over year, FCF Margin gained in three of the last four quarters, with an average year-over-year change of +3005.29 percentage points.
- The high point for year-over-year FCF Margin in five years was Q1 2025 (a gain of 8871.88 percentage points); the low point was Q1 2024 (a drop of 8400.56 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | BioCorRx | 3.46 Mn | 2.80 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -201.81% |
| Sep 30, 2025 | -99.88% |
| Jun 30, 2025 | -70.97% |
| Mar 31, 2025 | -511.21% |
| Jun 30, 2024 | -3,754.59% |
| Mar 31, 2024 | -9,383.09% |
| Dec 31, 2023 | -2,818.86% |
| Sep 30, 2023 | -3,455.38% |
| Jun 30, 2023 | -2,910.84% |
| Mar 31, 2023 | -982.53% |
| Dec 31, 2022 | -542.44% |
| Sep 30, 2022 | -389.47% |
| Jun 30, 2022 | -2,197.88% |
| Mar 31, 2022 | -4,253.20% |
| Dec 31, 2021 | -4,757.39% |
| Sep 30, 2021 | -7,051.33% |
| Jun 30, 2021 | -8,513.99% |
| Mar 31, 2021 | -9,206.89% |
| Dec 31, 2020 | -1,548.72% |
| Sep 30, 2020 | -2,020.12% |
API Access
BioCorRx FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=BICX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "BICX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=BICX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();